Electronic implementation of a novel surveillance paradigm for ventilator-associated events feasibility and validation

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 8, 2014, Pages 947-955

  Klouwenberg, Peter M C Klein ^a,b   Van Mourik, Maaike S M ^a   Ong, David S Y ^a,b   Horn, Janneke ^c   Schultz, Marcus J ^c   Cremer, Olaf L ^a   Bonten, Marc J M ^a,b  

^a Department of Medical Microbiology ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Critical care; Mortality; Surveillance; Validation; Ventilator associated pneumonia

Indexed keywords

AGED; ALGORITHMS; COHORT STUDIES; FEASIBILITY STUDIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; NETHERLANDS; PATIENT ADMISSION; PNEUMONIA, VENTILATOR-ASSOCIATED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL SURVEILLANCE; SURVIVAL RATE;

EID: 84898986179     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201307-1376OC     Document Type: Article

References (31)

1. Association for Professionals in Infection Control and Epidemiology (APIC). HAI reporting laws and regulations. 2011 [accessed 2014 Mar]. Available from: http://www.apic.org/Resource-/TinyMceFileManager/Advocacy-PDFs/HAI-map.gif
2. Klevens RM, Edwards JR, Richards CL Jr., Horan TC, Gaynes RP, Pollock DA, Cardo DM. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160-166.
3. Panzer RJ, Gitomer RS, Greene WH, Webster PR, Landry KR, Riccobono CA. Increasing demands for quality measurement. JAMA 2013;310:1971-1980.
4. Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, Dudeck MA, Pollock DA, Horan TC. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37:783-805.
5. van der Kooi TI, Mannie? n J, Wille JC, van Benthem BH. Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies. J Hosp Infect 2010;75:168-172.
6. Melsen WG, Rovers MM, Groenwold RH, Bergmans DC, Camus C, Bauer TT, Hanisch EW, Klarin B, Koeman M, Krueger WA, et al. Attributable mortality of ventilator-associated pneumonia: a metaanalysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013;13:665-671.
7. Skrupky LP, McConnell K, Dallas J, Kollef MH. A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria. Crit Care Med 2012;40:281-284.
8. Uçkay I, Ahmed QA, Sax H, Pittet D. Ventilator-associated pneumonia as a quality indicator for patient safety? Clin Infect Dis 2008;46:557-563.
9. Michetti CP, Fakhry SM, Ferguson PL, Cook A, Moore FO, Gross R; AAST Ventilator-Associated Pneumonia Investigators. Ventilatorassociated pneumonia rates at major trauma centers compared with a national benchmark: a multi-institutional study of the AAST. J Trauma Acute Care Surg 2012;72:1165-1173.
10. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36: 309-332.
11. Klompas M. Interobserver variability in ventilator-associated pneumonia surveillance. Am J Infect Control 2010;38:237-239.
12. Fabregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, de La Bellacasa JP, Bauer T, Cabello H. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate postmortem lung biopsies. Thorax 1999;54:867-873.
13. Klompas M. Eight initiatives that misleadingly lower ventilatorassociated pneumonia rates. Am J Infect Control 2012;40:408-410.
14. Lin MY, Bonten MJ. The dilemma of assessment bias in infection control research. Clin Infect Dis 2012;54:1342-1347.
15. Klompas M, Khan Y, Kleinman K, Evans RS, Lloyd JF, Stevenson K, Samore M, Platt R; CDC Prevention Epicenters Program. Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS One 2011;6: e18062.
16. National Healthcare Safety Network (NHSN). The National Healthcare Safety Network device-associated module: ventilator-associated event protocol. Atlanta, GA: Centers for Disease Control and Prevention; July 2013.
17. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, et al. Developing a new, national approach to surveillance for ventilator-associated events. Crit Care Med 2013;41:2467-2475.
18. Klein Klouwenberg PM, Van Mourik MS, Ong DS, Cremer OL, Bonten MJ. Validation of a new surveillance algorithm for ventilator associated pneumonia [abstract]. European Society of Clinical Microbiology and Infectious Diseases (ECCMID): Berlin; 2013.
19. Van Mourik MS, Klein Klouwenberg PM, Ong DS, Schultz MJ, Horn J, Cremer OL, Bonten MJ. Validation and assessment of the new surveillance paradigm for ventilator-associated events [abstract]. Antimicrob Resist Infect Control 2013;2:O64.
20. Klein Klouwenberg PM, Ong DS, Bos LD, de Beer FM, van Hooijdonk RT, Huson MA, Straat M, van Vught LA, Wieske L, Horn J, et al. Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med 2013;41:2373-2378.
21. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
22. Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008;61: 1216-1221.
23. Beyersmann J, Allignol A, Schumacher M. Competing risks and multistate models with R. New York: Springer; 2012.
24. Hayashi Y, Morisawa K, Klompas M, Jones M, Bandeshe H, Boots R, Lipman J, Paterson DL. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis 2013;56: 471-477.
25. Muscedere J, Sinuff T, Heyland DK, Dodek PM, Keenan SP, Wood G, Jiang X, Day AG, Laporta D, Klompas M. The clinical impact and preventability of ventilator-associated conditions in critically ill mechanically ventilated patients. Chest 2013;144:1453-1460.
26. Ding S, Kilickaya O, Senkal S, Gajic O, Hubmayr RD, Li G. Temporal trends of ventilator-associated pneumonia incidence and the effect of implementing health-care bundles in a suburban community. Chest 2013;144:1461-1468.
27. Klompas M, Magill S, Robicsek A, Strymish JM, Kleinman K, Evans RS, Lloyd JF, Khan Y, Yokoe DS, Stevenson K, et al.; CDC Prevention Epicenters Program. Objective surveillance definitions for ventilatorassociated pneumonia. Crit Care Med 2012;40:3154-3161.
28. ARDSNet. Mechanical ventilation protocol summary of the NIH NHLBI ARDS Clinical Network [accessed March 2014]. Available from: http://www.ardsnet.org/ system/files/Ventilator%20Protocol% 20Card.pdf
29. Bosman RJ, Oudemane van Straaten HM, Zandstra DF. The use of intensive care information systems alters outcome prediction. Intensive Care Med 1998;24:953-958.
30. Liberati A, D'Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev [serial on the Internet]. 2009 [accessed March 2014]; 4:CD000022. Available from: http://summaries.cochrane.org/
31. Bonten MJ. Healthcare epidemiology: ventilator-associated pneumonia: preventing the inevitable. Clin Infect Dis 2011;52: 115-121.